Peter BAILLIE

Relocated back to Australia since mid 2024, I continue to provide adhoc Consultancy Services specific to my Healthcare experience in Business Development (Due Diligence for acquisition & integration projects) and Education & Training related to Commercial & Marketing Excellence.

Lead and strengthen the Commercial (Sales & Marketing) aspects across ANZ for several Business Units: Healthcare, Veterinary, Simulation & Dental (Excluding Technical Services) which quickly evolved to include the integration and rebranding of several diverse business acquisition integrations within an extremely short period.

Manage the South East Asia (SEA) Region of Direct (SG) and Indirect (TW, HK, TH, MY, PH, VN, ID) commercial channels. Build a High Performance team to deliver market-leading growth by establishing a SEA Leadership Team. Develop and enhance SEA Business Process which resulted in significant Profit improvements and Market Share Gains across the SEA Region.

Benchmark, Establish and Amplify Commercial Best Practice across the APAC region in collaboration with all Functional Departments to Accelerate Growth across APAC.

Led the $1.6B APAC Commercial Excellence Annual Marketing Planning process to focus resources, drive profitability and ignite growth. Hong Kong - 2021 Great Place to Work - Site Lead responsible for employee safety & engagement. APAC Training Centre Manager delivering accelerated regional Mako Smart Robotics capability and new site initiation. Pioneered MedEd Live & On-Demand Digital Marketing. MedEd launched Mako TKA in China through COVID.

Build Franchise specific Commercial Excellence to accelerate growth. Build and Chair regional Business Unit Councils. Conduct analysis and business reviews to identify business opportunities. Partner with countries to develop talent, share best practice and optimize resource deployment to maximize Go-To-Market launch impact. Represent the region/franchise on all Business Development Due Diligence and Integration projects.

Reversed a 7y Shoulder Arthroplasty market share decline. Reengineered the Shoulder Arthroplasty Surgeon Advisory Board and Portfolio Priorities. Championed the VariAx2 Project which has today become the #1 Brand for Stryker Trauma.

Create new standards in Academic Thought Leadership through the creation and management of specialty Surgeon Advisory Boards. Drive meaningful and competitive Extremities portfolio expansion (Foot/Ankle, Hand/Wrist/Forearm, and Shoulder/Elbow) through an appropriate and sustainable mix of organic (Build) or inorganic (Buy) strategic deployment of resources. Restructure and Lead R&D through Quality Systems Improvement Plan (QSIP) to deliver on new FDA corporate standards.

Lead all Due Diligence and integration projects for the Stryker Trauma & Extremities Division. Partner with Stryker Europe through their "Expedition for Growth" journey to optimize all Commercial Excellence activities. Chair regular in-country business reviews and align Matrix Organization actions and resources to mutually agreed goals. Representative member on the Global Portfolio Review and Compliance Committees.

Commercial Business Lead with Strategic and P&L accountability to drive market leading growth. Realign organization from a state GM based structure to a National Sales & Marketing / Functional Matrix structure. Deliver on all Talent, Engagement and Performance (Revenue, Profit, Inventory, Cash Flow) metrics.

Delivered 5x new multi-million dollar OEM partnership contracts. Owned Global Product Portfolio Management including Brand messaging and positioning. Drive Thought Leadership in OrthoBiologics. Key executive member for Due Diligence in all acquisition and integration projects. Deliver on all sustainable business growth commitments.

Reengineer the International Support Team and Independent Distribution Network delivering 300% growth.

Setup and drive product adoption via a new EU "Pharma" regulated sales team for Stryker’s' only Pharma regulated Biologic (OP-1 / BMP-7). Build out a KOL base to support new product adoption and clinical Thought Leadership.

Perform EU Business Reviews and share best practice. Coordinate and Lead (indirectly) all local Trauma Marketing teams.

Own the vision and execution of the global P&S portfolio product life cycle including effective integration, branding and PLCM execution following acquisitions.

Various roles with progressively increasing commercial leadership through: Operations, Sales (with 100% budget achievement record), Marketing and Global Product Management when I was transferred from Australia to Switzerland (NOTE: Synthes Australia was the ANZ distributor as part of the Mathys company which are now both now part of JNJ)